From: Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study
Gender | p rate | ||
---|---|---|---|
Male | Female | ||
Peritoneal carcinomatosis total | 1287 (41.0%) | 1850 (59.0%) | < 0.001 |
Malignant neoplasm of the colon and rectum (C18–C20) | 423 (49.1%) | 438 (50.9%) | 0.609 |
Malignant neoplasm of the ovary (C56) | – | 489 (100.0%) | – |
Malignant neoplasm of the stomach (C16) | 209 (51.2%) | 199 (48.8%) | 0.621 |
Malignant neoplasm of the pancreas (C25) | 193 (50.9%) | 186 (49.1%) | 0.719 |
Malignant neoplasm of the trachea, bronchus, and lung (C33, C34) | 112 (63.3%) | 65 (36.7%) | < 0.001 |
Malignant neoplasm of the gallbladder and biliary tract (C23, C24) | 63 (37.7%) | 104 (62.3%) | 0.002 |
Malignant neoplasm of the liver and intrahepatic bile ducts (C22) | 77 (62.1%) | 47 (37.9%) | 0.007 |
Malignant neoplasm of the uterus (C54, C55) | – | 116 (100.0%) | – |
Other locality of the primary tumor | 210 (50.5%) | 206 (49.5%) | 0.845 |